Wells Fargo Maintains Overweight on Scotts Miracle Gro, Lowers Price Target to $60

Benzinga Newsdesk www.benzinga.com Negative 87.1%

Neg 87.1% Neu 0% Pos 0%

Wells Fargo analyst Chris Carey maintains Scotts Miracle Gro (NYSE:SMG) with a Overweight and lowers the price target from $77 to $60.